Shimoda, S., Sato, M., Sekigami, T., Motoshima, H., Yoshimura, R., Fukuda, K., . . . Ono, K. (2016). A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study). John Wiley and Sons Inc.

Shimoda, Seiya, et al. A 1‐year, Prospective, Observational Study of Japanese Outpatients With Type 1 and Type 2 Diabetes Switching From Insulin Glargine or Detemir to Insulin Degludec in Basal–bolus Insulin Therapy (Kumamoto Insulin Degludec Observational Study). John Wiley and Sons Inc, 2016.

Shimoda, Seiya, et al. A 1‐year, Prospective, Observational Study of Japanese Outpatients With Type 1 and Type 2 Diabetes Switching From Insulin Glargine or Detemir to Insulin Degludec in Basal–bolus Insulin Therapy (Kumamoto Insulin Degludec Observational Study). John Wiley and Sons Inc, 2016.